home · filing · 0001193125-24-133170
8-K filed May 7, 2024, 7:59 PM ET
ticker TYRA
CIK 0001863127
leadership
confidence high
sentiment neutral
materiality 0.40
Tyra Biosciences appoints Drs. Moran and Rothenberg to Board; Dr. Chen resigns
Tyra Biosciences, Inc.
Isan Chen resigned from Board and Compensation Committee effective May 7, 2024, with no disagreement.
Board expanded from nine to ten and appointed Susan Moran (former CMO, RayzeBio) and S. Michael Rothenberg (CMO, insitro) as directors.
Moran appointed to Compensation and Science/Technology Committees; Rothenberg to Science/Technology Committee.
Each new director received options for 37,200 shares vesting over 36 months plus cash compensation.
Both directors are deemed independent under Nasdaq listing standards.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
S. Michael Rothenberg
Director
TYRA ·
Tyra Biosciences, Inc.
Effective 2024-05-07
Filed May 7, 2024, 7:59 PM ET
appointed Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. as directors.
Appointed
Susan Moran
Director
TYRA ·
Tyra Biosciences, Inc.
Effective 2024-05-07
Filed May 7, 2024, 7:59 PM ET
appointed Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. as directors.
Departed
Isan Chen
Director
TYRA ·
Tyra Biosciences, Inc.
Effective 2024-05-07
Successor Susan Moran
Filed May 7, 2024, 7:59 PM ET
Isan Chen, M.D. resigned from the Board and the Compensation Committee of the Board effective as of May 7, 2024.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
S. Michael Rothenberg was appointed as Director at Tyra Biosciences, Inc..
Action appointed
Role Director
Exact text from the filing
appointed Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. as directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Susan Moran was appointed as Director at Tyra Biosciences, Inc..
Action appointed
Role Director
Exact text from the filing
appointed Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. as directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Isan Chen resigned as Director at Tyra Biosciences, Inc..
Action resigned
Role Director
Exact text from the filing
Isan Chen, M.D. resigned from the Board and the Compensation Committee of the Board effective as of May 7, 2024.
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-24-133170
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.